Our Services
Why Choose Us ?
Our unique value proposition bridges American business standards with India’s operational excellence, eliminating traditional offshore coordination challenges while delivering measurable outcomes:
Complete Clinical Trials
Regulatory Excellence
AI Data Management
FSP Programs
Safety & Medical Writing
Regulatory Strategy
Medical Device Trials
Complete Clinical Trials
Regulatory Excellence
AI Data Management
FSP Programs
Safety & Medical Writing
Regulatory Strategy
Medical Device Trials
Our Core Offerings
Our unique value proposition bridges American business standards with India’s operational excellence, eliminating traditional offshore coordination challenges while delivering measurable outcomes:
01
Complete Clinical Trials
Phase I-IV Research Programs
End-to-end clinical research across all phases. 240+ sites, 100% inspection pass rate.
02
Regulatory Excellence
4-5 Week CDSCO Approvals
Expert regulatory consulting with proven 150+ clearances, 98% success rate.
02
Regulatory Excellence
4-5 Week CDSCO Approvals
Expert regulatory consulting with proven 150+ clearances, 98% success rate.
03
AI Data Management
ClintrialX Platform
4-week database lock with machine learning. 65% reduction in manual review cycles.
04
FSP Programs
Technology-Enhanced Operations
60% oversight reduction, 4-6X ROI guaranteed. Flexible engagement models, 450+ professionals.
04
FSP Programs
Technology-Enhanced Operations
60% oversight reduction, 4-6X ROI guaranteed. Flexible engagement models, 450+ professionals.
05
Safety & Medical Writing
AI-Enhanced Monitoring
Automated safety reporting and AI medical writing. Zero critical findings, full compliance.
06
Regulatory Strategy
Breakthrough Therapy Support
Expedited pathways for orphan drugs & breakthrough therapies. FDA, EMA, and CDSCO expertise.
06
Regulatory Strategy
Breakthrough Therapy Support
Expedited pathways for orphan drugs & breakthrough therapies. FDA, EMA, and CDSCO expertise.
07
Medical Device Trials
Class I, II, III Support
Manufacturing licenses in 6-8 weeks. Expert biotech & device clinical evaluation.
